Regulus Therapeutics (RGLS) Return on Equity (ROE) (2012 - 2025)
Regulus Therapeutics (RGLS) Return on Equity (ROE) from Dec 31, 2012 to Mar 31, 2025. The TTM Regulus Therapeutics (RGLS) Return on Equity (ROE) is -13.96%. You can export chart.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Regulus Therapeutics (RGLS)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2024 | -60.67% | -57.20% |
| 2023 | -141.76% | +66.64% |
| 2022 | -85.07% | +68.12% |
| 2021 | -50.60% | -16.27% |
| 2020 | -60.43% | -34.92% |
| 2019 | -92.86% | -111.15% |
| 2018 | 832.65% | -507.87% |
| 2017 | -204.15% | +39.89% |
| 2016 | -145.93% | +224.80% |
| 2015 | -44.93% | +4.65% |
| 2014 | -42.94% | +114.93% |
| 2013 | -19.98% | -28.76% |
| 2012 | -28.04% | N/A |